Le Lézard1d
Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update
Announced positive data from the Phase 1 clinical trial of ELVN-001 in CML, reporting a cumulative MMR rate of 44% (8/18) by 24 weeks and showing that ELVN-001 remains well-tolerated with no dose ...
One new company’s AI technology is making content go viral
One new company quietly gaining traction as a must-have in this space is RAD Intel, which leverages AI within a highly ...
Taiwan News8d
ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year
Developed by Ascentage Pharma, olverembatinib is the first China -approved third-generation BCR:ABL1 inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent ...
Wall Street Journal15d
HIVE Digital Technologies Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Chase Mining Acquires Revolutionary Graphite Technology
Chase Mining Corporation Limited (AU:GCM) has released an update. Chase Mining Corporation Limited has acquired an innovative technology to ...
Morningstar16d
Coronation Fund Managers Ltd
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
clinicaltrialsarena16d
Spero’s stock slides after antibiotic flops in Phase II trial
Spero’s SPR729 is a prodrug that converts into an active form that targets ATPase site of DNA gyrase B in mycobacteria. Image credit: Lemonsoup14 / Shutterstock. Spero Therapeutics has suspended the ...
Novartis Pharma AG: Novartis Scemblix FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile
Ad hoc announcement pursuant to Art. 53 LR Scemblix, a new first-line option for adults with CML, is first to show superior efficacy and favorable safety and tolerability profile in a Phase III trial ...
ET Auto20d
Govt proposes use of AI, innovative tech to check traffic violations: Gadkari
Gadkari also encouraged small firms with innovative technologies to participate in government tenders, stressing the importance of cost-effectiveness while maintaining profit margins without ...
Indiatimes21d
MosChip Technologies Announcement under Regulation 30 (LODR)-Newspaper Publication
Extraordinary General Meeting (EGM) scheduled to be held on Friday, 05-July-2024 at 04.00 p.m. MosChip Technologies Outcome Of Circular Resolution - Moschip EGM Rescheduled To Be Held On Friday, ...
Pharmaceutical Technology22d
Transforming CML patient monitoring with ICON’s innovative RNA-based NGS assay
ICON Specialty Laboratory Solutions has created a new, advanced test using next-generation sequencing (NGS) technology. Based on RNA technology, ICON’s new assay offers huge improvements on how CML is ...